Labeling of AI/ML-Based Software

Overview

About this study

The purpose of this study is to to specify the core labeling ingredients for AI/ML-based medical devices and options for tailoring label information for different software device types and use cases to address the gap in effective communication and transparency about AI/ML development and use.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Mayo Clinic clinicians (MD, DO, or equivalent).

Exclusion Criteria:

  • None.

Eligibility last updated 4/27/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Barbara Barry, Ph.D.

Closed for enrollment

Contact information:

Austin Stroud M.A.

(507) 422-9362

Stroud.Austin@mayo.edu

More information

Publications

Publications are currently not available